(4r)-3-((2s)-3-mercapto-2-methylpropanoyl)-4- thiazolidinecarboxylic acid has been researched along with ubenimex in 1 studies
Studies ((4r)-3-((2s)-3-mercapto-2-methylpropanoyl)-4- thiazolidinecarboxylic acid) | Trials ((4r)-3-((2s)-3-mercapto-2-methylpropanoyl)-4- thiazolidinecarboxylic acid) | Recent Studies (post-2010) ((4r)-3-((2s)-3-mercapto-2-methylpropanoyl)-4- thiazolidinecarboxylic acid) | Studies (ubenimex) | Trials (ubenimex) | Recent Studies (post-2010) (ubenimex) |
---|---|---|---|---|---|
14 | 0 | 0 | 930 | 43 | 182 |
Protein | Taxonomy | (4r)-3-((2s)-3-mercapto-2-methylpropanoyl)-4- thiazolidinecarboxylic acid (IC50) | ubenimex (IC50) |
---|---|---|---|
Aminopeptidase B | Rattus norvegicus (Norway rat) | 6 | |
M1 family aminopeptidase | Plasmodium falciparum FcB1/Columbia | 0.284 | |
Cytosol aminopeptidase | Bos taurus (cattle) | 1.0005 | |
72 kDa type IV collagenase | Homo sapiens (human) | 6.45 | |
Leukotriene A-4 hydrolase | Homo sapiens (human) | 1.4742 | |
Aminopeptidase N | Homo sapiens (human) | 2.6333 | |
Aminopeptidase N | Sus scrofa (pig) | 3.8211 | |
Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 2.7 | |
Puromycin-sensitive aminopeptidase | Homo sapiens (human) | 3.5 | |
Bacterial leucyl aminopeptidase | Vibrio proteolyticus | 1.0005 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ban, M; Enomoto, H; Fujimura, K; Horiuchi, M; Miyake, Y; Mizuchi, M; Morikawa, Y; Suhara, H; Tsuji, F | 1 |
1 other study(ies) available for (4r)-3-((2s)-3-mercapto-2-methylpropanoyl)-4- thiazolidinecarboxylic acid and ubenimex
Article | Year |
---|---|
Synthesis and biological evaluation of N-mercaptoacylproline and N-mercaptoacylthiazolidine-4-carboxylic acid derivatives as leukotriene A4 hydrolase inhibitors.
Topics: Animals; Carboxylic Acids; Chemistry, Pharmaceutical; Crystallography, X-Ray; Drug Design; Epoxide Hydrolases; Humans; Inhibitory Concentration 50; Leukotriene A4; Models, Chemical; Proline; Structure-Activity Relationship; Sulfhydryl Compounds; Thiazolidines | 2008 |